Company Filing History:
Years Active: 2024
Title: Innovations of Jagadeesh Prasad Dasappa
Introduction
Jagadeesh Prasad Dasappa is a notable inventor based in Mangalagangothri, India. He has made significant contributions to the field of pharmaceuticals, particularly in developing anti-tubercular agents. With a total of four patents to his name, Dasappa's work is recognized for its potential impact on public health.
Latest Patents
Dasappa's latest patents include (E)-2-(3-Cyano-4-isobutoxyphenyl)-N'-(substituted benzylidene)-4-methylthiazole-5-carbohydrazides, which are novel arylhydrazones derivatives. These compounds are synthesized through a specific method and are formulated into a pharmaceutical composition that includes a suitable carrier. The arylhydrazones derivative compounds are particularly useful as anti-tubercular agents, showcasing Dasappa's commitment to addressing critical health issues.
Career Highlights
Jagadeesh Prasad Dasappa is affiliated with King Fahd University of Petroleum and Minerals, where he continues to engage in innovative research. His academic and professional journey reflects a dedication to advancing pharmaceutical sciences and improving treatment options for tuberculosis.
Collaborations
Dasappa has collaborated with notable colleagues, including Katharigatta N Venugopala and Pran Kishore Deb. These partnerships have likely contributed to the success and development of his innovative research.
Conclusion
Jagadeesh Prasad Dasappa's work in developing anti-tubercular agents through innovative compounds highlights his significant contributions to the field of pharmaceuticals. His patents and collaborations reflect a commitment to improving health outcomes and advancing scientific knowledge.